Management of Restless Legs Syndrome in a Fatigued Patient
Start by checking iron status immediately—measure serum ferritin and transferrin saturation—and treat with iron supplementation if ferritin is <75 mcg/L or transferrin saturation is <20%, as this addresses a reversible cause before considering medications 1.
Initial Evaluation: What to Look For
When a tired patient presents with restless legs, focus your history on these specific diagnostic criteria:
- Urge to move the legs that worsens with rest or inactivity
- Symptoms that improve with movement (walking, stretching)
- Evening/nighttime predominance of symptoms
- Impact on sleep initiation or maintenance (present in ~90% of RLS patients) 1
Ask directly: "Do you have an uncomfortable urge to move your legs when sitting or lying down that gets better when you move?" This distinguishes RLS from mimics like neuropathy, leg cramps, or positional discomfort 1.
The fatigue you're seeing is likely secondary to the sleep disruption caused by RLS, not a separate issue 2. Studies show RLS patients score significantly worse on fatigue measures compared to those without RLS 2.
Treatment Algorithm
Step 1: Iron Repletion (First-Line for Everyone)
Check these labs on every patient:
- Serum ferritin
- Transferrin saturation
Treat with oral iron if ferritin <75 mcg/L or transferrin saturation <20% 1. The 2025 AASM guideline makes this a conditional recommendation with moderate certainty of evidence 1. The updated 2026 algorithm emphasizes new indications for both oral and IV iron therapy 3.
Step 2: Review Medications
Identify and stop or switch any medications that worsen RLS:
- Antihistamines (diphenhydramine)
- Antidepressants (SSRIs, SNRIs, mirtazapine)
- Antipsychotics
- Antiemetics (metoclopramide, prochlorperazine)
The 2026 algorithm specifically highlights the role of medications in exacerbating RLS 3.
Step 3: Non-Pharmacological Interventions for Intermittent RLS
If symptoms occur less than twice weekly, try behavioral approaches first 3:
- Regular moderate exercise (shown effective in reducing RLS severity) 4
- Pneumatic compression devices (effective for both RLS severity and sleep) 4
- Sleep hygiene optimization
- Avoid caffeine and alcohol in the evening
Step 4: Pharmacologic Therapy for Chronic Persistent RLS
For symptoms ≥2 times per week causing moderate distress, start with gabapentinoids as first-line pharmacologic therapy 3, 5:
- Gabapentin enacarbil 600 mg or pregabalin 150-300 mg
- These are now preferred over dopamine agonists due to augmentation risk
Critical shift in 2025 guidelines: Dopamine agonists (pramipexole, ropinirole, rotigotine) were downgraded from first-line therapy because of accumulating evidence of augmentation—a worsening of RLS symptoms with earlier onset, increased severity, and spread to other body parts 1, 5. If dopamine agonists are used, they require careful monitoring and precautions 3.
Step 5: Refractory Cases
For patients who fail gabapentinoids:
Low-dose opioids (methadone 5-10 mg, oxycodone 5-15 mg) have an important role and can be used safely with proper monitoring 3, 5. The National RLS Opioid Registry showed reassuring safety data 5.
Bilateral peroneal nerve stimulation demonstrated efficacy and safety as adjunct therapy 5.
Buprenorphine is emerging as a novel therapy option 3.
Common Pitfalls to Avoid
- Don't start dopamine agonists as first-line therapy—the 2025 guideline explicitly downgraded these due to augmentation risk 1, 5
- Don't assume normal ferritin means adequate iron—RLS patients need ferritin >75 mcg/L, higher than standard "normal" ranges 1
- Don't overlook medication-induced RLS—many common drugs worsen symptoms 3
- Don't use valerian (suggested against by AASM) 1
Special Populations
- Pregnancy/lactation: Requires modified approach (detailed in 2026 algorithm) 3
- End-stage renal disease: Consider vitamin C supplementation; avoid standard use of levodopa or rotigotine 1
- Children: Use ferrous sulfate if appropriate iron parameters are met 1
The fatigue will improve as RLS symptoms are controlled and sleep quality improves 2.